Search Results for keywords:"Rockville Maryland"

The Atomic Safety and Licensing Board has been restructured following the retirement of Administrative Judge Paul S. Ryerson on November 30, 2024. Administrative Judge G. Paul Bollwerk, III will now serve as the Presiding Officer in the ongoing legal case concerning Yucca Mountain Nevada High-Level Waste Geologic Repository. This reconstitution ensures that all legal correspondence and documents will continue to be filed through the NRC's electronic filing system as usual. This change was formalized in Rockville, Maryland, on December 3, 2024.

The Nuclear Regulatory Commission (NRC) announced its meeting schedule for the upcoming weeks, starting December 23, 2024, and extending into January 2025. No meetings are planned for most of these weeks, except on January 14, 2025, when a public meeting will be held to discuss the Strategic Programmatic Overview of the Decommissioning and Low-Level Waste and Nuclear Materials Users Business Lines. The meeting will take place in Rockville, Maryland, and can also be viewed live via webcast. The NRC provides accommodations for individuals with disabilities and offers contact information for those needing assistance or wishing to obtain electronic notices.

The National Cancer Institute has announced a change to the schedule of the Special Emphasis Panel meeting on clinical and translational cancer research. Originally scheduled to end at 7 p.m. on February 5, 2025, the meeting will now conclude earlier, at 2 p.m. The meeting, held from February 4-5, 2025, will take place at the National Cancer Institute in Rockville, Maryland, and will remain closed to the public.

The Advisory Committee on Childhood Vaccines (ACCV), part of the Health Resources and Services Administration within the Department of Health and Human Services, has announced plans for public meetings throughout 2021. These meetings will occur on four dates: March 4, June 3, September 2, and December 2, all running from 10:00 a.m. to 4:00 p.m. Eastern Time. The meetings may be held in person in Rockville, Maryland, or via teleconference and webinar, and the public is invited to participate. The ACCV advises on the National Vaccine Injury Compensation Program and related issues, and attendees are encouraged to submit comments or questions in advance.

The National Cancer Institute is holding several meetings to discuss grant applications and contract proposals. These meetings will be closed to the public to protect confidential information, such as trade secrets and personal data. The meetings will take place in March and May 2021 at the National Cancer Institute in Rockville, Maryland, using telephone conference calls. Contact information for the scientific review officers in charge of each meeting is provided for those needing further details.

The National Institute of Allergy and Infectious Diseases (NIAID) announced a closed meeting on January 9, 2025, for evaluating contract proposals related to diagnostics for specific diseases. The meeting will be held virtually at the NIAID offices in Rockville, Maryland. It will discuss sensitive information such as trade secrets and personal data, which is why it is not open to the public. Shilpakala Ketha, a Scientific Review Officer at NIAID, is the contact person for this meeting.

The National Institute on Deafness and Other Communication Disorders announced two closed virtual meetings to review and evaluate grant applications. These meetings will take place on April 2 and April 4, 2025, at the National Institutes of Health in Rockville, Maryland. The discussions will be private because they might reveal confidential information such as trade secrets, commercial property, or personal details that could invade privacy. The meetings are part of the Federal Advisory Committee and will be conducted under the guidance of the respective Scientific Review Officers, Dr. Kausik Ray and Dr. Andrea B. Kelly.

The Nuclear Regulatory Commission (NRC) released a notice about their upcoming public meetings for early 2025, covering weeks from January 6 to February 10. Meetings are tentatively scheduled on January 14 and February 6, with topics including the decommissioning and waste management program and ADVANCE Act activities. Locations for the meetings are in Rockville, Maryland, and they will also be accessible online for public viewing. The NRC encourages the public, including individuals with disabilities requiring accommodations, to attend or reach out for more information.

The National Institute of Allergy and Infectious Diseases has announced a closed meeting to be held on January 28, 2025. This meeting will take place from 10:00 a.m. to 12:00 p.m. and will focus on reviewing and evaluating grant applications. The discussions will be private to prevent the disclosure of confidential information, such as trade secrets or personal data related to the grant applications. The meeting will be conducted via video at the National Institutes of Health in Rockville, Maryland.

The National Institute of Allergy and Infectious Diseases is holding a closed meeting on May 13-14, 2025, to discuss grant applications related to anti-infective and immune disease therapeutics. This meeting will be conducted via video and will not be open to the public to protect confidential information and personal privacy. The meeting will take place from 10:00 a.m. to 6:00 p.m. at a location in Rockville, Maryland. The contact person for this meeting is Louis A. Rosenthal, Ph.D., who can be reached by email or phone for further information.